Key elements for designing and performing a CRISPR/Cas9-based genetic screen

Wanjing Shang^{a, b, c, #},
Fei Wang^{a, b, c, #},
Gaofeng Fan^{a
, ,},
Haopeng Wang^{a
, ,}

a.
School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China
b.
Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
c.
University of Chinese Academy of Sciences, Beijing 100049, China

More Information

Corresponding author: E-mail address: fangf@shanghaitech.edu.cn (Gaofeng Fan); E-mail address: wanghp@shanghaitech.edu.cn (Haopeng Wang)

These authors contributed equally to this work.

摘要

- /
- /
Abstract: Reverse genetic screens are invaluable for uncovering gene functions, but are traditionally hampered by some technical limitations. Over the past few years, since the advent of the revolutionary CRISPR/Cas9 technology, its power in genome editing has been harnessed to overcome the traditional limitations in reverse genetic screens, with successes in various biological contexts. Here, we outline these CRISPR/Cas9-based screens, provide guidance on the design of effective screens and discuss the potential future directions of development of this field.
- CRISPR /
- Cas9 /
- Genetic screen
These authors contributed equally to this work.
注释:

HTML全文

参考文献(95)

[1]	Agrotis, A., Ketteler, R. A new age in functional genomics using CRISPR/Cas9 in arrayed library screening Front. Genet., 6 (2015),p. 300
[2]	Aguirre, A.J., Meyers, R.M., Weir, B.A. et al. Genomic copy number dictates a gene-independent cell response to CRISPR/Cas9 targeting Cancer Discov., 6 (2016),pp. 914-929
[3]	Arroyo, J.D., Jourdain, A.A., Calvo, S.E. et al. A genome-wide CRISPR death screen identifies genes essential for oxidative phosphorylation Cell Metab., 24 (2016),pp. 875-885
[4]	Bandell, M., Dubin, A.E., Petrus, M.J. et al. High-throughput random mutagenesis screen reveals TRPM8 residues specifically required for activation by menthol Nat. Neurosci., 9 (2006),pp. 493-500
[5]	Bassett, A.R., Tibbit, C., Ponting, C.P. et al. Cell Rep., 4 (2013),pp. 220-228
[6]	Bassett, A.R., Kong, L., Liu, J.L. J. Genet. Genomics, 42 (2015),pp. 301-309
[7]	Berns, K., Hijmans, E.M., Mullenders, J. et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway Nature, 428 (2004),pp. 431-437
[8]	Birsoy, K., Wang, T., Chen, W.W. et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis Cell, 162 (2015),pp. 540-551
[9]	Boutros, M., Ahringer, J. The art and design of genetic screens: RNA interference Nat. Rev. Genet., 9 (2008),pp. 554-566
[10]	Budhu, S., Loike, J.D., Pandolfi, A. et al. J. Exp. Med., 207 (2010),pp. 223-235
[11]	Cerami, E., Gao, J., Dogrusoz, U. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data Cancer Discov., 2 (2012),pp. 401-404
[12]	Chapman, K.M., Medrano, G.A., Jaichander, P. et al. Targeted germline modifications in rats using CRISPR/Cas9 and spermatogonial stem cells Cell Rep., 10 (2015),pp. 1828-1835
[13]	Chen, S., Sanjana, N.E., Zheng, K. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis Cell, 160 (2015),pp. 1246-1260
[14]	Chen, W., Zhang, Y., Yeo, W.S. et al. J. Am. Chem. Soc., 139 (2017),pp. 3790-3795
[15]	Chi, S., Weiss, A., Wang, H. A CRISPR-based toolbox for studying T cell signal transduction Biomed. Res. Int., 2016 (2016),p. 5052369
[16]	Cho, S.W., Lee, J., Carroll, D. et al. Genetics, 195 (2013),pp. 1177-1180
[17]	Cong, L., Ran, F.A., Cox, D. et al. Multiplex genome engineering using CRISPR/Cas systems Science, 339 (2013),pp. 819-823
[18]	Dang, Y., Jia, G., Choi, J. et al. Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency Genome Biol., 16 (2015),p. 280
[19]	Deans, R.M., Morgens, D.W., Okesli, A. et al. Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification Nat. Chem. Biol., 12 (2016),pp. 361-366
[20]	DiCarlo, J.E., Norville, J.E., Mali, P. et al. Nucleic Acids Res., 41 (2013),pp. 4336-4343
[21]	Dixit, A., Parnas, O., Li, B. et al. Perturb-Seq: dissecting molecular circuits with scalable single-cell RNA profiling of pooled genetic screens Cell, 167 (2016),pp. 1853-1866
[22]	Doench, J.G., Fusi, N., Sullender, M. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 Nat. Biotechnol., 34 (2016),pp. 184-191
[23]	Donovan, K.F., Hegde, M., Sullender, M. et al. Creation of novel protein variants with CRISPR/Cas9-mediated mutagenesis: turning a screening by-product into a discovery tool PLoS One, 12 (2017),p. e0170445
[24]	Gayle, S., Landrette, S., Beeharry, N. et al. Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma Blood, 129 (2017),pp. 1768-1778
[25]	Gilbert, L.A., Horlbeck, M.A., Adamson, B. et al. Genome-scale CRISPR-mediated control of gene repression and activation Cell, 159 (2014),pp. 647-661
[26]	Guo, D., Liu, H., Gao, G. et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells Stem Cell Res., 17 (2016),pp. 670-672
[27]	Gwack, Y., Sharma, S., Nardone, J. et al. Nature, 441 (2006),pp. 646-650
[28]	Haga, K., Fujimoto, A., Takai-Todaka, R. et al. Functional receptor molecules CD300lf and CD300ld within the CD300 family enable murine noroviruses to infect cells Proc. Natl. Acad. Sci. U. S. A., 113 (2016),pp. E6248-E6255
[29]	Hai, T., Teng, F., Guo, R. et al. One-step generation of knockout pigs by zygote injection of CRISPR/Cas system Cell Res., 24 (2014),pp. 372-375
[30]	Han, X., Liu, Z., Zhao, L. et al. Microfluidic cell deformability assay for rapid and efficient kinase screening with the CRISPR-Cas9 system Angew. Chem. Int. Ed. Engl., 55 (2016),pp. 8561-8565
[31]	Han, K., Jeng, E.E., Hess, G.T. et al. Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions Nat. Biotechnol., 35 (2017),pp. 463-474
[32]	Hart, T., Chandrashekhar, M., Aregger, M. et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities Cell, 163 (2015),pp. 1515-1526
[33]	Hedlund, E., Deng, Q. Single-cell RNA sequencing: technical advancements and biological applications Mol. Asp. Med. (2017)
[34]	Hong, A.L., Tseng, Y.Y., Cowley, G.S. et al. Integrated genetic and pharmacologic interrogation of rare cancers Nat. Commun., 7 (2016),p. 11987
[35]	Horlbeck, M.A., Gilbert, L.A., Villalta, J.E. et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation eLife, 5 (2016),p. e19760
[36]	Hrabe de Angelis, M.H., Flaswinkel, H., Fuchs, H. et al. Genome-wide, large-scale production of mutant mice by ENU mutagenesis Nat. Genet., 25 (2000),pp. 444-447
[37]	Hsu, P.D., Lander, E.S., Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering Cell, 157 (2014),pp. 1262-1278
[38]	Hultquist, J.F., Schumann, K., Woo, J.M. et al. A Cas9 ribonucleoprotein platform for functional genetic studies of HIV-host interactions in primary human T cells Cell Rep., 17 (2016),pp. 1438-1452
[39]	Jaitin, D.A., Weiner, A., Yofe, I. et al. Dissecting immune circuits by linking CRISPR-pooled screens with single-cell RNA-seq Cell, 167 (2016),pp. 1883-1896
[40]	Joung, J., Konermann, S., Gootenberg, J.S. et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening Nat. Protoc., 12 (2017),pp. 828-863
[41]	Katigbak, A., Cencic, R., Robert, F. et al. A CRISPR/Cas9 functional screen identifies rare tumor suppressors Sci. Rep., 6 (2016),p. 38968
[42]	Keng, V.W., Villanueva, A., Chiang, D.Y. et al. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma Nat. Biotechnol., 27 (2009),pp. 264-274
[43]	Klein, A.M., Mazutis, L., Akartuna, I. et al. Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells Cell, 161 (2015),pp. 1187-1201
[44]	Koike-Yusa, H., Li, Y., Tan, E.P. et al. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library Nat. Biotechnol., 32 (2014),pp. 267-273
[45]	Konermann, S., Brigham, M.D., Trevino, A.E. et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex Nature, 517 (2015),pp. 583-588
[46]	Korkmaz, G., Lopes, R., Ugalde, A.P. et al. Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9 Nat. Biotechnol., 34 (2016),pp. 192-198
[47]	Kurata, M., Rathe, S.K., Bailey, N.J. et al. Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML Sci. Rep., 6 (2016),p. 36199
[48]	Larson, M.H., Gilbert, L.A., Wang, X. et al. CRISPR interference (CRISPRi) for sequence-specific control of gene expression Nat. Protoc., 8 (2013),pp. 2180-2196
[49]	Lee, S.S., Lee, R.Y., Fraser, A.G. et al. Nat. Genet., 33 (2003),pp. 40-48
[50]	Li, W., Xu, H., Xiao, T. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens Genome Biol., 15 (2014),p. 554
[51]	Liu, S.J., Horlbeck, M.A., Cho, S.W. et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells Science, 355 (2017)
[52]	Ma, H., Dang, Y., Wu, Y. et al. A CRISPR-based screen identifies genes essential for West-Nile-virus-induced cell death Cell Rep., 12 (2015),pp. 673-683
[53]	Macosko, E.Z., Basu, A., Satija, R. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets Cell, 161 (2015),pp. 1202-1214
[54]	Maeder, M.L., Linder, S.J., Cascio, V.M. et al. CRISPR RNA-guided activation of endogenous human genes Nat. Methods, 10 (2013),pp. 977-979
[55]	Marceau, C.D., Puschnik, A.S., Majzoub, K. et al. Nature, 535 (2016),pp. 159-163
[56]	Nakayama, T., Fish, M.B., Fisher, M. et al. Genesis, 51 (2013),pp. 835-843
[57]	O'Donnell, K.A., Keng, V.W., York, B. et al. A sleeping beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer Proc. Natl. Acad. Sci. U. S. A., 109 (2012),pp. E1377-E1386
[58]	Orchard, R.C., Wilen, C.B., Doench, J.G. et al. Discovery of a proteinaceous cellular receptor for a norovirus Science, 353 (2016),pp. 933-936
[59]	Park, R.J., Wang, T., Koundakjian, D. et al. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors Nat. Genet., 49 (2017),pp. 193-203
[60]	Parnas, O., Jovanovic, M., Eisenhaure, T.M. et al. A genome-wide CRISPR screen in primary immune cells to dissect regulatory networks Cell, 162 (2015),pp. 675-686
[61]	Peng, J., Zhou, Y., Zhu, S. et al. High-throughput screens in mammalian cells using the CRISPR-Cas9 system FEBS J., 282 (2015),pp. 2089-2096
[62]	Rauscher, B., Heigwer, F., Breinig, M. et al. GenomeCRISPR - a database for high-throughput CRISPR/Cas9 screens Nucleic Acids Res., 45 (2017),pp. D679-D686
[63]	Ren, Q., Li, C., Yuan, P. et al. A dual-reporter system for real-time monitoring and high-throughput CRISPR/Cas9 library screening of the hepatitis C virus Sci. Rep., 5 (2015),p. 8865
[64]	Ruiz, S., Mayor-Ruiz, C., Lafarga, V. et al. A genome-wide CRISPR screen identifies CDC25A as a determinant of sensitivity to ATR inhibitors Mol. Cell, 62 (2016),pp. 307-313
[65]	Sanjana, N.E., Shalem, O., Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening Nat. Methods, 11 (2014),pp. 783-784
[66]	Sanjana, N.E., Wright, J., Zheng, K. et al. High-resolution interrogation of functional elements in the noncoding genome Science, 353 (2016),pp. 1545-1549
[67]	Savidis, G., McDougall, W.M., Meraner, P. et al. Identification of Zika virus and dengue virus dependency factors using functional genomics Cell Rep., 16 (2016),pp. 232-246
[68]	Schmid-Burgk, J.L., Chauhan, D., Schmidt, T. et al. A genome-wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation J. Biol. Chem., 291 (2016),pp. 103-109
[69]	Schumann, K., Lin, S., Boyer, E. et al. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins Proc. Natl. Acad. Sci. U. S. A., 112 (2015),pp. 10437-10442
[70]	Shah, A.N., Davey, C.F., Whitebirch, A.C. et al. Rapid reverse genetic screening using CRISPR in zebrafish Nat. Methods, 12 (2015),pp. 535-540
[71]	Shalem, O., Sanjana, N.E., Hartenian, E. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells Science, 343 (2014),pp. 84-87
[72]	Shan, Q., Wang, Y., Li, J. et al. Targeted genome modification of crop plants using a CRISPR-Cas system Nat. Biotechnol., 31 (2013),pp. 686-688
[73]	Sidik, S.M., Huet, D., Ganesan, S.M. et al. Cell, 166 (2016),pp. 1423-1435
[74]	Smith, F.M., Vearing, C., Lackmann, M. et al. Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen J. Biol. Chem., 279 (2004),pp. 9522-9531
[75]	Song, C.Q., Li, Y., Mou, H. et al. Genome-wide CRISPR screen identifies regulators of mitogen-activated protein kinase as suppressors of liver tumors in mice Gastroenterology, 152 (2017),pp. 1161-1173
[76]	Tan, J., Martin, S.E. Validation of synthetic CRISPR reagents as a tool for arrayed functional genomic screening PLoS One, 11 (2016),p. e0168968
[77]	Tian, R., Wang, H., Gish, G.D. et al. Combinatorial proteomic analysis of intercellular signaling applied to the CD28 T-cell costimulatory receptor Proc. Natl. Acad. Sci. U. S. A., 112 (2015),pp. E1594-E1603
[78]	Tzelepis, K., Koike-Yusa, H., De Braekeleer, E. et al. A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia Cell Rep., 17 (2016),pp. 1193-1205
[79]	Virreira Winter, S., Zychlinsky, A., Bardoel, B.W. Sci. Rep., 6 (2016),p. 24242
[80]	Waaijers, S., Portegijs, V., Kerver, J. et al. Genetics, 195 (2013),pp. 1187-1191
[81]	Wang, H., Yang, H., Shivalila, C.S. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering Cell, 153 (2013),pp. 910-918
[82]	Wang, T., Wei, J.J., Sabatini, D.M. et al. Genetic screens in human cells using the CRISPR-Cas9 system Science, 343 (2014),pp. 80-84
[83]	Wang, T., Birsoy, K., Hughes, N.W. et al. Identification and characterization of essential genes in the human genome Science, 350 (2015),pp. 1096-1101
[84]	Wu, Y., Zhou, L., Wang, X. et al. A genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A Cell Discov., 2 (2016),p. 16014
[85]	Xia, P., Zhang, X., Xie, Y. et al. Functional toxicogenomic assessment of triclosan in human HepG2 cells using genome-wide CRISPR-Cas9 screening Environ. Sci. Technol., 50 (2016),pp. 10682-10692
[86]	Xu, C., Qi, X., Du, X. et al. Proc. Natl. Acad. Sci. U. S. A., 114 (2017),pp. 722-727
[87]	Zhang, L., Reed, R.D. Genome editing in butterflies reveals that spalt promotes and Distal-less represses eyespot colour patterns Nat. Commun., 7 (2016),p. 11769
[88]	Zhang, S.L., Yeromin, A.V., Zhang, X.H. et al. Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity Proc. Natl. Acad. Sci. U. S. A., 103 (2006),pp. 9357-9362
[89]	Zhang, Y., Ge, X., Yang, F. et al. Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells Sci. Rep., 4 (2014),p. 5405
[90]	Zhang, R., Miner, J.J., Gorman, M.J. et al. A CRISPR screen defines a signal peptide processing pathway required by flaviviruses Nature, 535 (2016),pp. 164-168
[91]	Zheng, G.X., Terry, J.M., Belgrader, P. et al. Massively parallel digital transcriptional profiling of single cells Nat. Commun., 8 (2017),p. 14049
[92]	Zhong, C., Yin, Q., Xie, Z. et al. CRISPR-Cas9-mediated genetic screening in mice with haploid embryonic stem cells carrying a guide RNA library Cell Stem Cell, 17 (2015),pp. 221-232
[93]	Zhou, Y., Zhu, S., Cai, C. et al. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells Nature, 509 (2014),pp. 487-491
[94]	Zhu, S., Li, W., Liu, J. et al. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library Nat. Biotechnol., 34 (2016),pp. 1279-1286
[95]	Zuber, J., Shi, J., Wang, E. et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Nature, 478 (2011),pp. 524-528